Main > PHARMA. > Potassium Chloride. > Extended Release Oral Tablet. > Generic Version > Co.: USA. A > Patent > Claims > Claim 1: Oral Adm K Tablet Comprise > Plurality MicroPellets have Cores > of Soluble Potassium Salt; Each > MicroPellet: Water InSol. Coating: > EthylCellulose (70-90%) & Visc.< > 15 cp & Plasticizer; MicroPellets > Compressed into Tablet form. Claim > 2: Dosage Unit. Core Mesh Size= > 20-50 mesh. Claim 3: Coated Unit: > KCl=75-90%. Claim 4: Tablets:

---

KCl=75-90%. Claim 4: Tablets:'s subsections
MicroPellets; MicroCrystalline

KCl=75-90%. Claim 4: Tablets:'s products
This section has no products